Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV
- PMID: 15810069
- PMCID: PMC4305772
- DOI: 10.3748/wjg.v11.i14.2061
Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV
Abstract
Aim: To comprehend the risk factors of recurrence of hepatocellular carcinoma (HCC) and its relationship with the infection patterns of hepatitis B virus (HBV).
Methods: All materials of 270 cases of postoperative HCC were statistically analyzed by SPSS software. Recurrence and metastasis were classified into early (< or =2 years) and late phase (>2 years). Risk factors for recurrence and metastasis after surgery in each group were analyzed.
Results: Out of 270 cases of HCC, 162 cases were followed up in which recurrence and metastasis occurred in 136 cases. There were a lot of risk factors related to recurrence and metastasis of HCC; risk factors contributing to early phase recurrence were serum AFP level, vascular invasion, incisal margin and operative transfusion, gross tumor classification and number of intrahepatic node to late phase recurrence. The HBV infective rate of recurrent HCC was 94.1%, in which "HBsAg, HBeAb, HbcAb" positive pattern reached 45.6%. The proportion of HBV infection in solitary large hepatocellular carcinoma (SLHCC) evidently decreased compared to nodular hepatocellular carcinoma (NHCC) (P<0.05).
Conclusion: The early and late recurrence and metastasis after hepatectomy of HCC were associated with different risk factors. The early recurrence may be mediated by vascular invasion and remnant lesion, the late recurrence by tumor's clinical pathology propert, as multicentric carcinogenesis or intrahepatic carcinoma de novo. HBV replication takes a great role in this process. From this study, we found that SLHCC has more satisfactory neoplasm biological behavior than NHCC.
Figures
Similar articles
-
Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.Liver Int. 2016 Feb;36(2):284-92. doi: 10.1111/liv.12898. Epub 2015 Aug 28. Liver Int. 2016. PMID: 26104132
-
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.J Hepatol. 2003 Feb;38(2):200-7. doi: 10.1016/s0168-8278(02)00360-4. J Hepatol. 2003. PMID: 12547409
-
[Risk factors for metastasis and recurrence of hepatocellular carcinoma at different stages].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Oct;30(5):540-3. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005. PMID: 16320584 Chinese.
-
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
-
Recurrence and metastasis of hepatocellular carcinoma: progress and prospects.Hepatobiliary Pancreat Dis Int. 2002 Feb;1(1):35-41. Hepatobiliary Pancreat Dis Int. 2002. PMID: 14607620 Review.
Cited by
-
Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter.Gastroenterol Rep (Oxf). 2019 Aug;7(4):250-257. doi: 10.1093/gastro/goz009. Epub 2019 Mar 30. Gastroenterol Rep (Oxf). 2019. PMID: 31413831 Free PMC article.
-
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.World J Hepatol. 2014 Jun 27;6(6):384-93. doi: 10.4254/wjh.v6.i6.384. World J Hepatol. 2014. PMID: 25018849 Free PMC article. Review.
-
Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China.Liver Res. 2024 Nov 20;9(1):66-73. doi: 10.1016/j.livres.2024.11.003. eCollection 2025 Mar. Liver Res. 2024. PMID: 40206433 Free PMC article.
-
Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.BMC Cancer. 2021 Mar 16;21(1):283. doi: 10.1186/s12885-021-07969-4. BMC Cancer. 2021. PMID: 33726693 Free PMC article.
-
Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.Front Oncol. 2025 May 27;15:1462794. doi: 10.3389/fonc.2025.1462794. eCollection 2025. Front Oncol. 2025. PMID: 40496611 Free PMC article.
References
-
- Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322–326. - PubMed
-
- Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol. 2004;30:414–420. - PubMed
-
- Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg. 2004;198:356–365. - PubMed
-
- Huo TI, Lui WY, Wu JC, Huang YH, King KL, Loong CC, Lee PC, Chang FY, Lee SD. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg. 2004;28:258–262. - PubMed
-
- Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–207. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical